Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up
| Image |  |
|---|---|
| Description | scientific article published on 15 April 2009 |
| Author/s |
author: Martin S. Tallman Jorge Eduardo Cortes Jerald P Radich Ricardo Pasquini John DiPersio Hagop Kantarjian M Brigid Bradley-Garelik |
| Publication date | April 15, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |